Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progesterone Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01881230
What this trial is testing

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

Who this might be right for
Breast TumorBreast CancerCancer of the Breast+8 more
Celgene 191
Testing effectiveness (Phase 2)Study completedNCT03909152
What this trial is testing

Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone

Who this might be right for
Granulosa Cell Ovarian CancerLow Grade Serous Ovarian/ Primary Peritoneal CancerEndometrioid Endometrial Cancer
Memorial Sloan Kettering Cancer Center 34
Large-scale testing (Phase 3)Ended earlyNCT00925548
What this trial is testing

STRIDE - STimulating Immune Response In aDvanced brEast Cancer

Who this might be right for
Breast Cancer
EMD Serono 16
Testing effectiveness (Phase 2)Ended earlyNCT00210028
What this trial is testing

Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Institut Claudius Regaud 40
Large-scale testing (Phase 3)Looking for participantsNCT05601700
What this trial is testing

Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)

Who this might be right for
Carcinoma, Ovarian EpithelialLow Grade Serous Adenocarcinoma of Ovary
Ente Ospedaliero Ospedali Galliera 132
Testing effectiveness (Phase 2)Study completedNCT01818063
What this trial is testing

Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerProgesterone Receptor-negative Breast Cancer+5 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 9
Large-scale testing (Phase 3)Active Not RecruitingNCT01349322
What this trial is testing

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

Who this might be right for
Breast Cancer
Radiation Therapy Oncology Group 2,354
Testing effectiveness (Phase 2)Study completedNCT03691493
What this trial is testing

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor PositiveHER2/Neu Negative+4 more
Emory University 36
Large-scale testing (Phase 3)WithdrawnNCT03081234
What this trial is testing

Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)WithdrawnNCT06938711
What this trial is testing

A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Context Therapeutics Inc.
Testing effectiveness (Phase 2)Study completedNCT01151046
What this trial is testing

Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer

Who this might be right for
Her2 Negative Breast Cancer Patients
Merrimack Pharmaceuticals 118
Testing effectiveness (Phase 2)Study completedNCT01105312
What this trial is testing

Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 28
Testing effectiveness (Phase 2)Study completedNCT01124695
What this trial is testing

Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer

Who this might be right for
Breast CancerStage IV Breast Cancer
ECOG-ACRIN Cancer Research Group 124
Testing effectiveness (Phase 2)UnknownNCT03044730
What this trial is testing

Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+7 more
Northwestern University 30
Early research (Phase 1)Study completedNCT04081389
What this trial is testing

Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+16 more
Roswell Park Cancer Institute 9
Large-scale testing (Phase 3)Study completedNCT01547741
What this trial is testing

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 4,242
Testing effectiveness (Phase 2)Study completedNCT01750073
What this trial is testing

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+13 more
University of Nebraska 92
Testing effectiveness (Phase 2)Study completedNCT00290251
What this trial is testing

Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914

Who this might be right for
Leiomyoma
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 72
Testing effectiveness (Phase 2)Ended earlyNCT00592007
What this trial is testing

Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Carcinoma
Lyudmila Bazhenova, M.D. 7
Large-scale testing (Phase 3)Active Not RecruitingNCT02488967
What this trial is testing

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

Who this might be right for
Breast AdenocarcinomaEstrogen Receptor NegativeHER2/Neu Negative+7 more
NRG Oncology 782
Next Page